In response to investor worries following market disruptions due to regulatory measures, several smaller Chinese gaming companies have announced plans to buy back shares.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today provided an update on the grant and allowance of three patent applications for
Samsung Electronics Co (OTC: SSNLF) has shelved mass production plans at its new chip plant in Taylor, Texas, posing a bummer for the U.S.'s semiconductor dreams.